Table 3.
Pain intensity items | General ADL interference items | Facial ADL interference items | All PFPS-R items | |||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | Univariate | Multivariate | |
Dose rate (Gy/min) | 0.034 | 0.048 | 0.002 | 0.003 | 0.034 | 0.054 | 0.011 | 0.023 |
BED | 0.035 | 0.049 | 0.001 | 0.003 | 0.048 | 0.047 | 0.012 | 0.025 |
Age | 0.969 | 0.352 | 0.408 | 0.209 | 0.166 | |||
Brainstem dose (Gy) | 0.897 | 0.832 | 0.786 | 0.741 | ||||
Dx: TN1 vs. TN2 | 0.940 | 0.750 | 0.578 | 0.736 | ||||
Dx: TN1/2 vs. other | 0.174 | 0.157 | 0.551 | 0.105 | 0.101 | 0.342 | ||
Prior intervention | 0.857 | 0.300 | 0.403 | 0.862 | 0.366 | |||
Sex | 0.142 | 0.189 | 0.130 | 0.271 | 0.876 | 0.022 | 0.030 |
Table values are p-values of corresponding t-statistics, shown separately for univariate and multivariate regression models, where statistically-significant predictors on multivariate analysis are marked in bold. ADL: activities of daily living; TN 1/2: trigeminal neuralgia type 1/type 2, dx: diagnosis.